Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Increased [<sup>18</sup>F]FDG uptake in the infarcted myocardial area displayed by combined PET/CMR correlates with snRNA-seq-detected inflammatory cell invasion.

Basic research in cardiology·2024

Same author

Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis.

International journal of molecular sciences·2023

Same author

Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction.

Frontiers in bioengineering and biotechnology·2022

Same author

Novel Identified Circular Transcript of RCAN2, circ-RCAN2, Shows Deviated Expression Pattern in Pig Reperfused Infarcted Myocardium and Hypoxic Porcine Cardiac Progenitor Cells In Vitro.

International journal of molecular sciences·2021

Same author

Comparative Effect of MSC Secretome to MSC Co-culture on Cardiomyocyte Gene Expression Under Hypoxic Conditions <i>in vitro</i>.

Frontiers in bioengineering and biotechnology·2020

Same author

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.

European heart journal·2020

Search research articles

Related Experiment Video

Updated: Mar 31, 2026

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

Therapeutic oligonucleotides with polyethylene glycol modifications.

Johannes Winkler¹

¹Department of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, 1090 Vienna, Austria.

Future Medicinal Chemistry

|October 15, 2015

Summary

Polyethylene glycol (PEG) attachment to oligonucleotide drugs enhances stability and duration but impacts efficacy. Optimizing PEG chain length is crucial for balancing pharmacokinetic benefits with therapeutic activity.

More Related Videos

Chemical Triphosphorylation of Oligonucleotides

Chemical Triphosphorylation of Oligonucleotides

Published on: June 2, 2022

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Published on: July 28, 2017

Related Experiment Videos

Last Updated: Mar 31, 2026

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

Chemical Triphosphorylation of Oligonucleotides

Chemical Triphosphorylation of Oligonucleotides

Published on: June 2, 2022

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Published on: July 28, 2017

Area of Science:

Oligonucleotide therapeutics
Drug delivery systems
Pharmacology

Background:

Polyethylene glycol (PEG) attachment is a standard method for oligonucleotide drugs to resist enzymatic breakdown and renal clearance.
Oligonucleotides like Pegaptanib use PEG chains to improve drug accumulation and prolong effects after administration.
The molecular weight of PEG chains significantly influences drug behavior.

Purpose of the Study:

To investigate the impact of polyethylene glycol (PEG) chain length on the pharmacokinetic and pharmacodynamic properties of oligonucleotide drugs.
To understand the trade-offs between PEGylation for stability and its effects on drug efficacy.

Main Methods:

Analysis of PEG chain length effects on oligonucleotide drug properties.
Review of existing data on PEGylated oligonucleotides in clinical development.

Main Results:

Longer PEG chains extend drug circulation time but can reduce gene-silencing efficiency and binding affinity.
Shorter PEG chains offer less protection against renal filtration but may preserve gene-silencing and binding kinetics.
PEG chain length is a critical determinant of both drug stability and therapeutic performance.

Conclusions:

Optimizing PEG chain length is essential for balancing the pharmacokinetic advantages of PEGylation with the desired pharmacodynamic effects of oligonucleotide drugs.
Tailoring PEG chain length can enhance the therapeutic index of oligonucleotide-based therapies.